MHC-Optimized Peptide Scaffold for Improved Antigen Presentation and Anti-Tumor Response.

Front Immunol · 2021 · PMC8564487 · PMID 34745146

Europe PMC DOI

hedged sentence

0.3500

closest p · 7.0× alpha

0.3500

boldest claim

The sentences

showed a trendp = 0.35not close (p > 0.1)

In particular, when compared to the E7 wt, with or without the NAL modification in p4, the efficacy of E7-scaff peptides showed a trend of improvement which did not reach the statistical significance (p = 0.35) ( Figures 6A, B ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.